Nisa Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.53M | Buy |
|
|||||
|
2025
Q2 | $2.69M | Buy |
|
|||||
|
2025
Q1 | $2.2M | Sell |
|
|||||
|
2024
Q4 | $3.13M | Buy |
|
|||||
|
2024
Q3 | $3.17M | Buy |
|
|||||
|
2024
Q2 | $1.98M | Hold |
|
|||||
|
2024
Q1 | $1.22M | Hold |
|
|||||
|
2023
Q4 | $1.56M | Hold |
|
|||||
|
2023
Q3 | $1.44M | Hold |
|
|||||
|
2023
Q2 | $1.55M | Sell |
|
|||||
|
2023
Q1 | $2.07M | Sell |
|
|||||
|
2022
Q4 | $2.47M | Hold |
|
|||||
|
2022
Q3 | $2.08M | Sell |
|
|||||
|
2022
Q2 | $1.56M | Buy |
|
|||||
|
2022
Q1 | $1.27M | Sell |
|
|||||
|
2021
Q4 | $1.21M | Sell |
|
|||||
|
2021
Q3 | $5.76K | Buy |
|
|||||
|
2021
Q2 | $2.22K | Sell |
|
|||||
|
2021
Q1 | $4.38K | Buy |
|
|||||
|
2020
Q4 | $1.99M | Buy |
|
|||||
|
2020
Q3 | $1.81M | Sell |
|
|||||
|
2020
Q2 | $2.5M | Buy |
|
|||||
|
2020
Q1 | $1.36M | Buy |
|
|||||
|
2019
Q4 | $1.21M | Sell |
|
|||||
|
2019
Q3 | $3.25M | Buy |
|
|||||
|
2019
Q2 | $533K | Sell |
|
|||||
|
2019
Q1 | $1.09M | Buy |
|
|||||
|
2018
Q4 | $687K | Sell |
|
|||||
|
2018
Q3 | $860K | Buy |
|
|||||
|
2018
Q2 | $753K | Buy |
|
|||||
|
2018
Q1 | $179K | Sell |
|
|||||
|
2017
Q4 | $915K | Buy |
|
|||||
|
2017
Q3 | $764K | Hold |
|
|||||
|
2017
Q2 | $447K | Buy |
|
|||||
|
2017
Q1 | $256K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $156K | Hold |
|
|||||
|
2016
Q2 | $128K | Buy |
|